Carregant...
Budesonide and fluticasone propionate differentially affect the airway epithelial barrier
BACKGROUND: COPD patients have a higher risk of pneumonia when treated with fluticasone propionate (FP) than with placebo, and a lower risk with budesonide (BUD). We hypothesized that BUD and FP differentially affect the mucosal barrier in response to viral infection and/or cigarette smoke. METHODS:...
Guardat en:
| Publicat a: | Respir Res |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704248/ https://ncbi.nlm.nih.gov/pubmed/26739349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0318-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|